Evidence map›Paper›PMID 31336912›Full record

ReviewMolecules (Basel, Switzerland)2019

The Nervous System Relevance of the Calcium Sensing Receptor in Health and Disease.

Maria Lo Giudice, Balázs Mihalik, András Dinnyés, Julianna Kobolák

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Pooled it
  2. The effects of dairy products containingFrontiers in nutrition · 2026
    Trial
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Activation of CaExperimental brain research · 2025
    Article
  8. Review
  9. Article
  10. Biomolecular Basis of Life.Metabolites · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Maria Lo GiudiceBioTalentum Ltd., H-2100 Gödöllő, Hungary.
Balázs MihalikMolecular Animal Biotechnology Laboratory, Szent István University, H-2100 Gödöllő, Hungary.
András DinnyésBioTalentum Ltd., H-2100 Gödöllő, Hungary.
Julianna KobolákBioTalentum Ltd., H-2100 Gödöllő, Hungary. julianna.kobolak@biotalentum.hu.ORCID 0000-0002-0986-9517
Magyar Agrár- és Élettudományi Egyetem · HUBioTalentum (Hungary) · HU

Funding

H2020 Marie Skłodowska-Curie Actions 675228
6 · The paper itself

Abstract

The calcium sensing receptor (CaSR) was first identified in parathyroid glands, and its primary role in controlling systemic calcium homeostasis by the regulation of parathyroid hormone (PTH) secretion has been extensively described in literature. Additionally, the receptor has also been investigated in cells and tissues not directly involved in calcium homeostasis, e.g., the nervous system (NS), where it plays crucial roles in early neural development for the differentiation of neurons and glial cells, as well as in the adult nervous system for synaptic transmission and plasticity. Advances in the knowledge of the CaSR's function in such physiological processes have encouraged researchers to further broaden the receptor's investigation in the neuro-pathological conditions of the NS. Interestingly, pre-clinical data suggest that receptor inhibition by calcilytics might be effective in counteracting the pathomechanism underlying Alzheimer's disease and ischemia, while a CaSR positive modulation with calcimimetics has been proposed as a potential approach for treating neuroblastoma. Importantly, such promising findings led to the repurposing of CaSR modulators as novel pharmacological alternatives for these disorders. Therefore, the aim of this review article is to critically appraise evidence which, so far, has been yielded from the investigation of the role of the CaSR in physiology of the nervous system and to focus on the most recent emerging concepts which have reported the receptor as a therapeutic target for neurodegeneration and neuroblastic tumors.

Indexed as

Disease SusceptibilityNervous System Physiological PhenomenaAge FactorsAnimalsCalciumCell DifferentiationHumansMolecular Targeted TherapyNervous SystemNeurogenesisReceptors, Calcium-SensingSignal TransductionCalciumReceptors, Calcium-SensingAlzheimer’s diseasecalcilyticcalcimimeticcalcium-sensing receptorischemianervous systemneuroblastoma

Identifiers

PMID31336912
PMCPMC6680999
OpenAlexW2959358757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.